Michael Hoekstra
- Name
- M. Hoekstra MSc
- ORCID iD
- 0000-0003-1062-651X
- Ballantine R.D., Al Ayed U.K., Bann S.J., Hoekstra M., Martin N.I. & Cochrane S.A. (2023), Linearization of the brevicidine and laterocidine lipopeptides yields analogues that retain full antibacterial activity, Journal of Medicinal Chemistry 66(8): 6002-6009.
- Al Ayed U.K., Ballantine R.D., Hoekstra M., Bann S.J., Wesseling C.M.J., Bakker A.T., Zhong Z., Li Y.X., Brüchle N.C., Stelt M. van der, Cochrane S.A. & Martin N.I. (2022), Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy, Chemical Science 13(12): 3563-3570.
- Ballantine R.D., Al Ayed U.K., Bann S.J., Hoekstra M., Martin N.I. & Cochrane S.A. (2022), Synthesis and structure–activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine, RSC Medicinal Chemistry 13: 1640-1643.